MedPath

Endoscopic Treatment of the Buried Bumper Syndrome: Comparison of the Flamingo Device Versus Standard Therapy

Not Applicable
Completed
Conditions
Buried Bumper Syndrome
Interventions
Procedure: Standard Therapy
Device: Flamingo Device
Registration Number
NCT03186066
Lead Sponsor
Kliniken Ludwigsburg-Bietigheim gGmbH
Brief Summary

Percutaneous endoscopic gastrostomy (PEG) is a method for nutrition delivery for patients with insufficient oral intake. A rare but severe complication of PEG is the Buried Bumper Syndrome (BBS). In BBS the internal fixation device of the PEG migrates along the stoma chanel. The internal fixation disc becomes covered by gastric mucosa, which causes loss of patency, fixation of the PEG and possible leakage around the PEG.

BBS can be treated endoscopically by dissecting the overgrowing tissue with endoscopic submucosal dissection (ESD) knifes. A new and alternative approach is the use of the Flamingo device, which is inserted over the PEG and then is used to radially dissect the overgrowing tissue with a cutting wire.

In this study both methods, the standard method using an ESD knife and the Flamingo device, are compared in a randomized controlled open-label trial. Primary endpoint is the time needed for PEG removal.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Endoscopy proven Buried Bumper Syndrome
  • PEG or Jet-PEG
Exclusion Criteria
  • Major Coagulation disorder
  • Percutaneous endoscopic jejunostomy or use of a ballon fixed device

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard TherapyStandard TherapyBuried Bumper Syndrome is treated by endoscopically dissecting the overgrown tissue with an endoscopic submucosal dissection knife.
Flamingo DeviceFlamingo DeviceThe Flamingo device is used for treatment of Buried Bumper Syndrome.
Primary Outcome Measures
NameTimeMethod
Time for Removal of PEGAssessed at day 1 (day of intervention)
Secondary Outcome Measures
NameTimeMethod
Success rateAssessed at day 1
ComplicationsAssessed during follow-up for up to ten days

Trial Locations

Locations (1)

Klinikum Ludwigsburg

🇩🇪

Ludwigsburg, Germany

© Copyright 2025. All Rights Reserved by MedPath